Foot And Mouth Disease (FMD) Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

Industry Outlook

The global foot and mouth disease (FMD) vaccines market to reach US$ 3,886.07 Mn in 2030 and projected to exhibit a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2022 to 2030. FMD is highly contagious viral disease and sometimes fatal affecting cloven hoofed animals that includes domestic and wild bovids. Control and prevention of FMD needs vaccination, continuous monitoring, trade restrictions and isolations, or elimination of millions of animals to prevent the spread of the disease. The World Organization of Animal Health (OIE) classifies countries with the following stages with regards to FMD such as FMD present with or without vaccination, FMD free without vaccination and FMD free with vaccination. Countries classified as FMD-free without vaccination have the highest export for animal derived components; therefore these countries strive hard for maintain their current status by preventing the FMD viruses. Favorable government initiatives to prevent and restrict the FMD outbreaks have boosted the demand for FMD vaccines market. High prevalence of foot and mouth diseases in developing countries in Asia Pacific and Latin America are also assisting the steady growth of FMD vaccines market. Asia Pacific held the largest share in the global FMD vaccines market owing to the large number of cattle and dairy animals in developing countries such as India, Bangladesh, China, Hong Kong and Pakistan which as susceptible to FMD endemics. The FMD vaccines market consists of large number of local players operating in the market. Moreover, government subsidies and funding for vaccines production and consumptions have restricted the entry of large pharmaceutical companies to venture in the market.

Growing Demand for Oil-based Vaccines to Drive the Market

In 2021, conventional vaccines held the largest share in the global FMD vaccines market in terms of vaccine type. The rise in preventive vaccination programs in FMD endemic prone areas and developed countries such as U.S., Canada, and U.K. will continue to boost the market for conventional vaccines market during the forecast period. Conventional vaccines are further segmented in to aluminum hydroxide/saponin based vaccines and oil-based vaccines. The oil-based vaccines are anticipated to grow at the fastest rate during the forecast period from 2018 to 2026 owing to advantages associated with oil-based FMD such as initiation of high titers and longer antibody responses resulting in better protection. Emergency vaccines are also expected to grow at a steady rate during the forecast period owing to the growing cases of FMD in the developing region.

Asia Pacific to Lead the Foot and Mouth Disease Vaccines Market

In 2021, Asia Pacific held the largest share in the global FMD vaccines market owing to the presence of developing nations with high headcount of cattle, pigs and sheep those are susceptible for FMD viruses. Agriculture and dairy industry is one of the prime industries in countries such as India, China, Bangladesh, and Pakistan; hence, regular vaccination drives are conducted by government to prevent outbreak of FMD that would affect the dairy and agriculture industries. According to OIE the direct and indirect losses associated with FMD is approximately US$ 5 billion globally. The impact of FMD has led to the successful campaigns of disease eradication in developed regions in North America and Europe. Minimum cases of FMD in have been recorded in these regions, hence; FMD vaccines market will exhibit sluggish growth rate in the North America and Europe compared to other regions in the market.

Market is studied in order to understand the current and future market trends in the foot and mouth disease vaccines market. The market is estimated by providing the compounded annual growth rate (CAGR) and data forecast from 2018 to 2026. Strategic merger, acquisition and collaboration among the key players for developing innovative product pipeline mentioned in the business strategy section. The key players currently engaged in the foot and mouth disease market are Merck Animal Health, Brilliant Bio Pharma Ltd., Agrovet Co., Indian Immunologics Limited, Merial S.A.S, Inova Biotecnologia, Intervac (Pvt). Ltd among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Foot And Mouth Disease (FMD) Vaccines market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Foot And Mouth Disease (FMD) Vaccines market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Vaccine

• Conventional Vaccines
• Aluminum Hydroxide/Saponin based Vaccines
• Oil-based Vaccine
• Emergency Vaccines

Animal

• Cattle
• Sheep & Goat
• Swine
• Others (Deer, Antelope, Gazelle)

Region Segment (2020-2030; US$ Million)

• North America
• U.S.
• Canada
• Rest of North America
• UK and European Union
• UK
• Germany
• Spain
• Italy
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• Africa
• Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

• Pre Covid-19 situation
• Post Covid-19 situation

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Foot And Mouth Disease (FMD) Vaccines market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2030.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Foot And Mouth Disease (FMD) Vaccines market?
• Which is the largest regional market for Foot And Mouth Disease (FMD) Vaccines market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Foot And Mouth Disease (FMD) Vaccines market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Foot And Mouth Disease (FMD) Vaccines market worldwide?

This product will be delivered within 2 business days.